Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 47.00 46.10 47.90 48.10 45.60 45.60 1,018,418 16:35:23
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -2.9 -1.0 - 121

Futura Medical Share Discussion Threads

Showing 17276 to 17299 of 21600 messages
Chat Pages: Latest  696  695  694  693  692  691  690  689  688  687  686  685  Older
DateSubjectAuthorDiscuss
13/9/2019
09:58
46p to 28p now back to 32p.Should get back to at least 38p next week
sbb1x
13/9/2019
09:47
Shrewd move IMO
ragnarr
13/9/2019
09:05
Topped up again this morning, let's be clear, if patients want to continue using a drug that they aren't getting paid to use then they must be benefiting from it, otherwise nobody in their right mind would continue doing something for nothing, the Med Gel works! This is a strong buy
tiananmen
12/9/2019
21:05
Glavet - you are as genuine an investor as a fickly investing short thing that is as short as a genuine fickle in a short investment
ragnarr
12/9/2019
19:10
This you mean? Nominated Adviser and (sole) broker - Liberum Capital Limited
glavey
12/9/2019
18:52
httPS://www.futuramedical.com/content/investors/investor_centre.asp
j777j
12/9/2019
18:50
And what is Liberum's relationship with Futura?
glavey
12/9/2019
18:31
That grin on Mr Barder's face when asked about the 80 pct of participants continuing on MED did more to cause me to want to press the buy button than all the previous interviews, board rampings, etc. If that was just an act then he deserves an Oscar.
tommyl1
12/9/2019
16:24
"funding options which should be plentiful post a positive read-out while it noted that discussions are continuing with a number of potential out-licensing partners."
j777j
12/9/2019
14:30
And where do Liberum write "will be easy to raise money on the back of a phase 3 trial"?
glavey
12/9/2019
13:51
"Futura management adapted its strategic vision last year with a shift towards the prescription erectile dysfunction market. This shift was not easy but was the right decision and since then management has consistently delivered on cash burn and the operational execution of the on-going clinical study. As such it remains on-track to deliver a potentially game-changing read-out in December, one that we believe is far lower risk than is perceived by investors due to a combination of a cleverly designed clinical study and a proven molecule. BUY. "
j777j
12/9/2019
13:40
" in all likelihood such a raise will happen only if positive data is delivered in which case our value per share rises to at least £0.95 per share or more than twice the current price."
j777j
12/9/2019
13:35
valuation.
j777j
12/9/2019
13:25
"According to Liberum a successful phase 3 will lead to a 95p share price..." Where do Liberum write that it will lead to a 95p share price?
glavey
12/9/2019
12:50
Just wait for the army of shorters to have their day and they will move on and disappear - no point engaging
ragnarr
12/9/2019
11:47
According to Liberum a successful phase 3 will lead to a 95p share price and they will either do a deal and get funded for next stage or will be easy to raise money on the back of a phase 3 trial which is not a simple binary outcome,as they are many parts and ha s a high probablity of success as they are using a tried and tested drug.One that has an excellent safety profile over decades. They also point out that ex R&D costs are only around £1 million pa as it is an R&D co with low overheads and staff numbers.
j777j
12/9/2019
11:38
the company has always been a jam tomorrow outfit which has been fantastic for trading... however as i posted first thing yesterday the desperate need for cash meant i took my spread off the table and wont be back until after the placing...
pjj71
12/9/2019
11:32
Nothing has changed. The co is a couple of months away from a potential $1 billion sales pa Blockbuster drugs. Singer N+1 previously forecast $90 million in upfront and milestone payments alone. Liberum reckon they will get a 25% royalty rate. Any potential licencee will be weighing up whether it would be much cheaper to simply buy the co outright.
j777j
12/9/2019
11:17
Here we go back up, the fact is, the announcement made no difference to what we already knew, I've topped up again this morning and the big picture should be at the forefront of everyone's mind, Fum are sitting on a Med Gel and it is expected to be successful and we will see the share price break the 60 mark within the next few weeks
tiananmen
12/9/2019
11:06
I have just watched the JB interview with Proactive Investor.There is a very interesting moment when JB is asked about the significance of the large number of people who want to remain in the phrase 3 study.He smiles and refers to the fact that he can't say too much as it's a blind trial.He knows far more than he is allowed to disclose,and is confident of a position outcome.My one disappointment is that he was not more emphatic about the funding position.As I said yesterday nothing has changed since last years placing.This should be massive and I sensed JB wants to shout it from the roof tops but is constrained by the need to maintain the integrity of the phase 3 trial.
martinelwick
12/9/2019
10:42
"J7 where are you ?" "This is a classic example why most private investors never make money"
glavey
12/9/2019
10:32
I agree with this previous post - J7 where are you ? martinelwick 11 Sep '19 - 18:06 - 5791 of 5806 0 3 0 I imagine many punters have sold at a considerable loss today,because they have been panicked by MM manipulation.If a moment or two was spent studying today’s statement nothing has changed,save we are nearer the third phase results.Our expenditure is what was predicted a year ago.Our resources reflect that assumption.We are funded for a year.The whole future of the company is dependant upon a successful out come in December.It always has been. What did investors expect today that was not delivered? This is a classic example why most private investors never make money
mikethebike4
12/9/2019
10:26
Barder does own a reasonable chunk as do family trusts and friends of his. The only oddity is the most financially savvy / connected individual on the board ( ex head of beeson gregory ) only holds a paultry 92k which have mainly come as part of his remuneration
slicethepie
12/9/2019
09:53
Get some of this brutally underpriced gem : Asit Biotech (ASIT.BR) Market cap €24 M / Cash €10 Million / Phase 3 readout in December for their immunotherapy treatment for grass pollen (€500 Million peak sales potential)Unknown stock = Potential 10+ BAGGER GEM ...........GLTA Successful Pollen Season Confirms ASIT biotech On Track for Phase III Results of gp-ASIT+™ in December 2019 hxxps://www.globenewswire.com/news-release/2019/09/05/1911325/0/en/Successful-Pollen-Season-Confirms-ASIT-biotech-On-Track-for-Phase-III-Results-of-gp-ASIT-in-December-2019.html
ih_116147
Chat Pages: Latest  696  695  694  693  692  691  690  689  688  687  686  685  Older
ADVFN Advertorial
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210519 03:37:33